We are excited to announce that PEI has joined the list of provinces to have taken action and made Opsumit available through public funding!
top of page
Recent Posts
PHA Canada is proud to announce our latest submission to the Patented Medicines Pricing Review Board (PMPRB) this September. As the...
Merck has announced that WINREVAIR® (sotatercept) is now authorized for use in Canada in combination with standard pulmonary arterial...
bottom of page
Comments